mitomycin has been researched along with Uterine Cervical Neoplasms in 176 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and toxicity of the combination of mitomycin C, etoposide, cisplatin, and epirubicin (MEPA) as neoadjuvant therapy for patients with cervical adenocarcinoma." | 7.72 | A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix. ( Nishiura, K; Obata, H; Okugawa, T; Tabata, T; Tanaka, K; Toyoda, N; Yanoh, K, 2004) |
| "Between May 1990 and February 1995, 16 patients with adenocarcinoma or adenosquamous carcinoma of the uterine cervix were prescribed neoadjuvant chemotherapy consisting of cisplatin (50 mg/m2) on day 1, mitomycin C (10 mg/m2) on day 1, and etoposide (100 mg/m2) on days 1, 3, and 5 (MEP)." | 7.70 | Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix. ( Fukuda, K; Hara, K; Iwasaka, T; Nakao, Y; Sugimori, H; Uchiyama, M; Yokoyama, M, 1998) |
| "Forty patients with locally advanced cervical carcinoma were entered into a protocol utilizing the bolus administration of both mitomycin C (10 or 15 mg) on Day 1 and 5-fluorouracil (400 mg) on Day 1-5 followed by sequential pelvic irradiation on Day 6 between September 1980 and October 1985." | 6.18 | Bolus mitomycin C and 5-FU with sequential radiation for poor-prognosis locally advanced cervical cancer. ( Breen, JL; Denehy, TR; Eastman, R; Gregori, CA; SanFilippo, L, 1996) |
| " There was a significant correlation between the area under the time versus concentration curve (AUC) of MMC and the age of patients (r = 0." | 5.28 | Pharmacokinetic study of mitomycin C with emphasis on the influence of aging. ( Karato, A; Miya, T; Saijo, N; Sasaki, Y, 1992) |
| "Three hundred eligible patients with carcinoma of the cervix out of a total of 560, registered between July 1981 and June 1983 were randomized into receiving either radiotherapy alone or radiotherapy plus weekly injection of bleomycin 15 mg and mitomycin C4 mg." | 5.05 | Chemotherapy-radiotherapy combination in the treatment of carcinoma of the cervix. ( Dharmalingam, SK; Singh, P; Tan, CK; Tan, MK, 1985) |
| " Twenty-five cases of advanced cervical cancer (15 cases of stage II with high risks, 10 of stage III, referred to as the 254-S group) treated by NAC using nedaplatin, mitomycin C and peplomycin were compared with 30 cases (22 cases of stage II with high risks, 8 of stage III, referred to as the CDDP group) treated using cisplatin and mitomycin C which is the conventional regimen, in terms of measurable response, pathological response, rate of lymph node metastasis, cumulative survival rate, side effects and relapse style." | 4.82 | [Neoadjuvant intraarterial chemotherapy with nedaplatin, peplomycin and mitomycin C for advanced cervical cancer]. ( Aso, T; Ichimura, M; Ohara, M; Otsuka, I; Shimabukuro, K; Somekawa, Y; Terauchi, T; Tsugata, M; Umeki, H; Wakana, K; Yamaguchi, Y, 2003) |
| "The present study aimed to solubilize the antineoplastic agent, mitomycin C (MMC), in two nanoemulsions (NEs) consisting of different essential oils (ginger (Gi) and frankincense (Fr)) in order to examine their anticancer activities on the HeLa cervical cancer cells and MCF-7 breast cancer cells." | 3.88 | Cytotoxicity and apoptosis enhancement in breast and cervical cancer cells upon coadministration of mitomycin C and essential oils in nanoemulsion formulations. ( Al-Otaibi, WA; Alkhatib, MH; Wali, AN, 2018) |
| "Chemotherapy of cervical cancer is a difficult problem." | 3.75 | Chemotherapy of cervical cancer. ( Guthrie, D, 1985) |
| "To evaluate the efficacy and toxicity of the combination of mitomycin C, etoposide, cisplatin, and epirubicin (MEPA) as neoadjuvant therapy for patients with cervical adenocarcinoma." | 3.72 | A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix. ( Nishiura, K; Obata, H; Okugawa, T; Tabata, T; Tanaka, K; Toyoda, N; Yanoh, K, 2004) |
| "We retrospectively reviewed 47 patients with locally advanced or bulky cervical carcinoma treated with two courses of intraarterial infusion of cisplatin, doxorubicin, mitomycin C, and 5-fluorouracil (5-FU), followed by radical hysterectomy at our hospital between 1988 and 1995." | 3.70 | Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma. ( Kataoka, N; Konishi, I; Mandai, M; Mori, T; Nagata, Y; Nanbu, K; Tsuruta, Y, 1998) |
| "Between May 1990 and February 1995, 16 patients with adenocarcinoma or adenosquamous carcinoma of the uterine cervix were prescribed neoadjuvant chemotherapy consisting of cisplatin (50 mg/m2) on day 1, mitomycin C (10 mg/m2) on day 1, and etoposide (100 mg/m2) on days 1, 3, and 5 (MEP)." | 3.70 | Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix. ( Fukuda, K; Hara, K; Iwasaka, T; Nakao, Y; Sugimori, H; Uchiyama, M; Yokoyama, M, 1998) |
| "Cervical squamous carcinoma patients who were pathologically diagnosed with stage Ib-IIb from April 2012 to May 2013 in the general hospital of Chinese People's Libration Amy were enrolled." | 2.80 | A clinical Comparison of Lobaplatin or Cisplatin with Mitomycine and Vincristine in Treating Patients with Cervical Squamous Carcinoma. ( Chen, L; Li, WP; Liu, H; Yao, YQ; Zhao, EF, 2015) |
| "Patients with stage IB2, IIA2, or IIB squamous cell carcinoma of the uterine cervix were randomly assigned to receive either BOMP (bleomycin 7 mg days 1-5, vincristine 0." | 2.78 | Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102). ( Hiura, M; Kamura, T; Kasamatsu, T; Katsumata, N; Kobayashi, H; Kodama, S; Kuzuya, K; Mizunoe, T; Nakanishi, T; Saito, T; Shibata, T; Yaegashi, N; Yasugi, T; Yokota, H; Yoshikawa, H, 2013) |
| "CPT-11 combined with MMC can be effective against advanced or recurrent SCC of the uterine cervix." | 2.71 | Phase II study of irinotecan combined with mitomycin-C for advanced or recurrent squamous cell carcinoma of the uterine cervix: the JGOG study. ( Fujii, T; Fushiki, H; Hasegawa, K; Izumi, R; Nishida, M; Nishimura, R; Takizawa, K; Tanaka, T; Umesaki, N; Yamamoto, K, 2004) |
| "Patients with FIGO Stage IIIb cervical cancer show cancer propagation to pelvic side walls from the uterus, and the tumors cannot be completely removed by radical hysterectomy." | 2.71 | Preoperative chemotherapy with irinotecan and mitomycin for FIGO stage IIIb cervical squamous cell carcinoma: a pilot study. ( Kokawa, K; Tanaka, T; Umesaki, N, 2005) |
| "Mitomycin-C/cisplatin were used to treat 33 evaluable patients aged 29-67 years (median: 50 years)." | 2.70 | Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study. ( Anastasopoulou, A; Einhorn, N; Lacave, AJ; Mangioni, C; Neijt, JP; Pecorelli, S; Rotmensz, N; van der Burg, ME; van Oosterom, AT; Veenhof, CH; Vermorken, JB; Wagenaar, HC; Zola, P, 2001) |
| " The 'treatment protocol adherence' was evaluated by recalculation of the ideal protocol dose and its comparison with the actual delivered dosage at each cycle of chemotherapy." | 2.69 | Quality control in multicentric clinical trials. An experience of the EORTC Gynecological Cancer Cooperative Group. ( Favalli, G; Pecorelli, S; Renard, J; Van Oosterom, AT; Vantongelen, K; Vermorken, JB, 2000) |
| "Sixty women with advanced cervical cancer (30 patients with unfavorable Stage IIB and 30 patients with Stages III and IVA) were treated with CR comprising of a combination of external and intracavitary RT delivering between 7000 to 7500 cGy total to point A and 5890 to 6015 cGy to point B along with one cycle of 5-FU and mitomycin C and a second cycle of 5-FU and cis-platinum." | 2.68 | Final results of a phase II chemoradiation protocol for locally advanced cervical cancer: RTOG 85-15. ( Caplan, R; Flam, M; John, M; Quivey, J; Rotman, M; Russell, A; Steinfeld, A, 1996) |
| "Twenty-five patients with cervical cancer (4 post-operative cases with FIGO stage Ib or IIb, 2 with stage IV, and 19 recurrence) were treated with a new BOMP consisting of bleomycin (5 mg/body, drip, i." | 2.67 | [Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin]. ( Chen, JT; Fujimoto, I; Koi, S; Nakayama, K; Seimiya, Y; Shimizu, Y; Teshima, H; Yamakawa, Y; Yamauchi, K; Yokosuka, K, 1991) |
| "Patients were diagnosed with cervical cancer FIGO stage IIB to IVA with a histopathology of squamous cell carcinoma, adenosquamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma." | 2.50 | Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer. ( Katanyoo, K; Laopaiboon, M; Lumbiganon, P; Manusirivithaya, S; Supawattanabodee, B; Tangjitgamol, S, 2014) |
| "Among gynecologic cancers, ovarian cancer is treated with chemotherapy as a routine practice." | 2.41 | [Gynecologic cancer-evidenced based chemotherapy]. ( Ochiai, K, 2000) |
| "Occasional advanced cervical cancer patients do not meet the eligibility criteria because of renal dysfunction due to involvement of ureter." | 2.40 | [Consecutive low-dose cisplatin-based chemotherapy for gynecologic malignancies]. ( Shimizu, Y, 1997) |
| "Locally advanced cervical cancer has a poor prognosis, poor survival rate, and high local failure rate." | 2.40 | [Clinical evaluation of chemoradiotherapy for advanced cervical cancer]. ( Kaneyasu, Y; Okawa, MK; Okawa, T, 1997) |
| "The cervical cancer has already attained high survival rate and there is a little room to improve the prognosis." | 2.38 | [Perspectives and plans to improve the prognosis of cervical cancer]. ( Sugimori, H, 1990) |
| "Piperine and MMC co-treatment resulted in a dose-dependent suppression of the cell proliferation." | 1.46 | Piperine (PP) enhanced mitomycin-C (MMC) therapy of human cervical cancer through suppressing Bcl-2 signaling pathway via inactivating STAT3/NF-κB. ( Cui, LD; Han, SZ; Liu, HX; Xu, Y; Yang, LQ, 2017) |
| "A pathologic cervical residual tumor was observed in 16 patients (35." | 1.43 | [Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy]. ( Ballester, M; Daraï, E; Huguet, F; Lauratet, B; Lefranc, JP; Monnier, L; Touboul, E, 2016) |
| "By using cervical cancer cells and differentiated macrophages, we demonstrate that MMC induces the expression of FasL via upregulation of PPARγ in both cell types (effector cells) in vitro, but it failed to induce bystander killing in cervical cancer cells." | 1.42 | Proteasomal inhibition sensitizes cervical cancer cells to mitomycin C-induced bystander effect: the role of tumor microenvironment. ( Ajay, AK; Bhat, MK; Chaube, B; Malvi, P; Meena, AS; Mohammad, N; Singh, SV, 2015) |
| "Patients with stage IB1 cervical cancer with tumor size larger than 2 cm who wish to preserve fertility." | 1.40 | Neoadjuvant intra-arterial chemotherapy followed by total laparoscopic radical trachelectomy in stage IB1 cervical cancer. ( Guo, H; Guo, S; Liu, C; Lu, Q; Wang, S; Zhang, Y; Zhang, Z, 2014) |
| "Cervical cancer is one of the leading causes of female cancer death worldwide with about 500,000 deaths per year." | 1.34 | The apoptotic effect of intercalating agents on HPV-negative cervical cancer C-33A cells. ( Kang, YH; Kim, JH; Kim, SH; Lee, KA; Paik, SG; Park, SN; Yang, Y; Yoon, DY, 2007) |
| "31 patients with advanced cervical cancer qualified for the study." | 1.33 | Preliminary results of mitomycin C local application as post-treatment prevention of vaginal radiation-induced morbidity in women with cervical cancer. ( Fijuth, J; Markowska, J; Pietraszek, A; Sobotkowski, J, 2006) |
| "The standard therapy for invasive uterine cervical cancer causes loss of the woman's fertility." | 1.33 | A case of successful pregnancy after treatment of invasive cervical cancer with systemic chemotherapy and conization. ( Akiyama, F; Hasumi, K; Kobayashi, Y, 2006) |
| "Patients with advanced stage invasive cervical cancer (CC) exhibit highly complex genomic alterations and respond poorly to conventional treatment protocols." | 1.32 | Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer. ( Arias-Pulido, H; Basso, K; Dürst, M; Gissmann, L; Mansukhani, M; Meyer, L; Murty, VV; Nandula, SV; Narayan, G; Pothuri, B; Schneider, A; Sugirtharaj, DD; Vargas, H; Villella, J, 2004) |
| "The prognosis of locally advanced cervix cancers is poor with metastatic and local recurrence risks." | 1.31 | [Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998]]. ( Beuzeboc, P; Chauveinc, L; Clough, KB; Cosset, JM; de la Rochefordière, A; Guyonnet, M; Mouret-Fourme, E; Nguyen, D, 2002) |
| "Among patients with uterine cervical cancer, glassy-cell carcinoma is very rare." | 1.31 | Response of glassy-cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C. ( Ezawa, S; Fukuchi, T; Komuro, Y; Mikami, M; Mukai, M; Sakaiya, N; Tei, C, 2000) |
| "Mitomycin C was one of the first chemotherapeutic agents to be shown to have preferential cytotoxicity toward hypoxic cells in vitro." | 1.31 | Effects of mitomycin C on the oxygenation and radiosensitivity of murine and human tumours in mice. ( Durand, RE; LePard, NE, 2000) |
| "We presented a case of locally advanced cervical cancer treated by intraarterial infusion chemotherapy, and evaluated the blood flow of uterine arteries before and after chemotherapy by using a transvaginal ultrasonic color Doppler device." | 1.31 | Blood flow after intraarterial infusion chemotherapy in a patient with advanced cervical cancer. ( Minagawa, Y; Onohara, Y; Takahashi, H; Tsudo, T, 2001) |
| " There was no significant nausea or vomiting, nephrotoxicity, or pulmonary toxicity, which was attributable to the CLD-cisplatin and the adequate dosing schedule of bleomycin." | 1.30 | Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma. ( Akiyama, F; Hasumi, K; Ishiya, T; Shimizu, Y; Umezawa, S; Utsugi, K, 1998) |
| "The response rate was higher in squamous cell carcinomas (85%) than adenocarcinomas or adenosquamous carcinomas (67%)." | 1.30 | [Neoadjuvant chemotherapy for advanced cervical cancer]. ( Hongo, A; Ikuhashi, H; Kobashi, Y; Kodama, J; Kudo, T; Miyagi, Y; Mizutani, Y; Okuda, H; Yoshinouchi, M, 1999) |
| "Fifteen patients with squamous cell carcinoma of the uterine cervix--7 in stage II, 6 in stage III and 2 in stage IV--were considered not to respond at the end of radiotherapy." | 1.29 | [Loco-regional intra-arterial chemotherapy combined with radiotherapy in cervical carcinoma]. ( Raffetto, N; Salvatori, F; Trinci, C; Trinci, M, 1993) |
| " There was a significant correlation between the area under the time versus concentration curve (AUC) of MMC and the age of patients (r = 0." | 1.28 | Pharmacokinetic study of mitomycin C with emphasis on the influence of aging. ( Karato, A; Miya, T; Saijo, N; Sasaki, Y, 1992) |
| "Seventeen patients with recurrent cervical cancer were prospectively treated with a combination of bleomycin, vincristine, and mitomycin C (BOM)." | 1.28 | Bleomycin, vincristine, and mitomycin C (BOM) as second-line treatment after failure of cis-platinum-based combination chemotherapy for recurrent cervical cancer. ( Goplerud, DR; Krebs, HB; Wheelock, JB, 1990) |
| "A total of 10 uterine cervical cancer patients (stage IIb 2, stage IIIb 6, stage IVb 2) were treated two times with selective intra-arterial injection of combined drugs of CDDP, ADR, 5-FU, MMC before operation or radiation therapy." | 1.28 | [Transcatheter intra-arterial injection of combination drugs in case of advanced uterine cervical cancer]. ( Abe, M; Honda, T; Kinashi, Y; Mori, T; Nagata, Y; Tai, S; Takai, I, 1990) |
| "Patients with advanced, recurrent cervical cancer who have failed radiation therapy often have underlying renal compromise." | 1.28 | Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity. ( Chambers, JT; Chambers, SK; Del Prete, SA; Flynn, SD; Schwartz, PE, 1989) |
| " The toxicities in the case of intra-arterial infusion were less prominent than in the case of intravenous administration of the same dosage of the oncostatics." | 1.27 | [Intra-arterial infusion of oncostatics in recurrent cervical carcinoma]. ( Iijima, S; Inaba, J; Kawagoe, K; Sasaki, J; Tsunoda, H, 1983) |
| "The principle treatment of cervical cancer now consists of surgery and radiotherapy, which have produced excellent treatment results." | 1.27 | [Problems in the treatment of cervical carcinoma]. ( Kohno, I; Sekiba, K, 1983) |
| "Thirty-three patients with advanced cervical cancer (31 squamous cancer, two adenosquamous cancer) previously untreated with cytotoxic drugs, were treated with bleomycin, 5 mg daily, for seven days and mitomycin C, 10 mg, on day 8." | 1.27 | Bleomycin-mitomycin C in advanced carcinoma of the cervix. A third look. ( Gullberg, B; Johnsson, JE; Mattsson, W; Sigurdsson, K; Simonsen, E; Stendahl, U; Tropé, C, 1983) |
| "Twenty women with recurrent squamous cell carcinoma of the cervix were treated with bleomycin followed by adriamycin and mitomycin-C." | 1.27 | Assessment of bleomycin, adriamycin and mitomycin-C in the treatment of recurrent cervical cancer. ( Blackledge, G; Chan, KK; Lawton, FG; Luesley, DM; Meanwell, CA; Mould, JJ; Perren, TJ, 1985) |
| "Ten patients with advanced squamous cell carcinoma of the uterine cervix received induction chemotherapy with cis-platinum, mitomycin-C, vincristine, and bleomycin (BOMP) over a 5 week period, followed by radiotherapy with concomitant weekly cisplatinum." | 1.27 | Combined chemotherapy and radiation therapy for advanced carcinoma of the cervix. ( Bloomer, WD; Cohen, C; Dalton, JF; Dottino, P; Goodman, HM; Kredentser, D; Lipsztein, R, 1987) |
| "Seventeen patients with recurrent uterine cervical cancer were treated with combination chemotherapy consisting of consecutive intravenous drip infusion of PEP 5 mg for 6 days and intravenous infusion of MMC 10 mg on the 6th day." | 1.27 | [Clinical effect of combination chemotherapy with peplomycin and mitomycin C (PM therapy) in recurrent uterine cervical cancer]. ( Chiba, T; Hiura, M; Kaneko, H; Tanaka, M; Yokoyama, T; Yorishima, M, 1988) |
| "Twenty-one patients with squamous carcinoma of the genital tract were treated with bleomycin, Oncovin, mitomycin-C, and cisplatin (BOMP)." | 1.27 | Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas. ( Belinson, JL; McClure, M; Richards, AL; Stewart, JA, 1985) |
| "Mitomycin-C (MMC) is an alkylating agent which has shown significant activity in gynecologic cancers, both in vivo and in vitro." | 1.27 | Pharmacokinetics of mitomycin-C in plasma and tumor tissue of cervical cancer patients and in selected tissues of female rats. ( Boike, G; Deppe, G; Gove, N; Malviya, VK; Young, JD, 1986) |
| "The AGT of the cervical cancer group was shorter than that of the control group, but it was not statistically significant." | 1.27 | Spontaneous and MMC induced SCE in lymphocytes from patients with cervical cancer. ( Ozawa, N; Sasamoto, K; Sho, K; Sou, S; Suzuki, M; Takabayashi, T; Yajima, A, 1986) |
| "Baseline and mitomycin C (MMC)-induced chromosomal aberrations and sister chromatid exchanges (SCEs) in blood lymphocytes of patients with cervical precancerous and cancerous lesions and normal women were studied." | 1.27 | Mitomycin C induced chromosomal aberrations and sister chromatid exchanges (SCEs) in lymphocytes of patients with precancerous and cancerous lesions of the uterine cervix. ( Das, BC; Luthra, UK; Mitra, AB; Murty, VV; Sharma, A, 1987) |
| "Nine patients with advanced cervical cancer were treated with a combination chemotherapy (MVP) consisting of mitomycin C 8 mg/m2 i." | 1.27 | [A combination chemotherapy using mitomycin C, vincristine and cisplatin (MVP) for advanced cervical cancer]. ( Adachi, K; Horikoshi, N; Ikeda, K; Inagaki, J; Inoue, K; Nakada, H; Ogawa, M; Tada, A; Usui, N; Yamazaki, H, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 57 (32.39) | 18.7374 |
| 1990's | 48 (27.27) | 18.2507 |
| 2000's | 53 (30.11) | 29.6817 |
| 2010's | 18 (10.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishibashi, F | 1 |
| Tanabe, S | 1 |
| Oda, T | 1 |
| Iwao, M | 1 |
| Pawar, VU | 1 |
| Ghosh, S | 1 |
| Chopade, BA | 1 |
| Shinde, VS | 1 |
| Eid, W | 1 |
| Abdel-Rehim, W | 1 |
| Nakao, Y | 3 |
| Hashiguchi, M | 1 |
| Nishiyama, S | 1 |
| Aihara, S | 1 |
| Iwasaka, T | 6 |
| Yokoyama, M | 4 |
| Han, SZ | 1 |
| Liu, HX | 1 |
| Yang, LQ | 1 |
| Cui, LD | 1 |
| Xu, Y | 1 |
| Alkhatib, MH | 2 |
| Al-Otaibi, WA | 2 |
| Wali, AN | 2 |
| Katsumata, N | 1 |
| Yoshikawa, H | 1 |
| Kobayashi, H | 1 |
| Saito, T | 3 |
| Kuzuya, K | 1 |
| Nakanishi, T | 1 |
| Yasugi, T | 1 |
| Yaegashi, N | 1 |
| Yokota, H | 1 |
| Kodama, S | 1 |
| Mizunoe, T | 1 |
| Hiura, M | 2 |
| Kasamatsu, T | 1 |
| Shibata, T | 1 |
| Kamura, T | 2 |
| Lu, Q | 1 |
| Zhang, Y | 1 |
| Wang, S | 1 |
| Guo, S | 1 |
| Guo, H | 1 |
| Zhang, Z | 1 |
| Liu, C | 1 |
| Carmona, R | 1 |
| Pritz, J | 1 |
| Bydder, M | 2 |
| Gulaya, S | 1 |
| Zhu, H | 1 |
| Williamson, CW | 1 |
| Welch, CS | 1 |
| Vaida, F | 1 |
| Bydder, G | 1 |
| Mell, LK | 2 |
| Tangjitgamol, S | 1 |
| Katanyoo, K | 1 |
| Laopaiboon, M | 1 |
| Lumbiganon, P | 1 |
| Manusirivithaya, S | 1 |
| Supawattanabodee, B | 1 |
| Li, WP | 1 |
| Liu, H | 2 |
| Chen, L | 1 |
| Yao, YQ | 1 |
| Zhao, EF | 1 |
| Li, Y | 2 |
| Lin, J | 1 |
| Yang, X | 1 |
| Wu, S | 1 |
| Huang, Y | 1 |
| Ye, S | 1 |
| Xie, L | 1 |
| Dai, L | 1 |
| Hou, Z | 1 |
| Singh, SV | 1 |
| Ajay, AK | 2 |
| Mohammad, N | 1 |
| Malvi, P | 1 |
| Chaube, B | 1 |
| Meena, AS | 1 |
| Bhat, MK | 2 |
| Monnier, L | 1 |
| Touboul, E | 1 |
| Daraï, E | 1 |
| Lefranc, JP | 1 |
| Lauratet, B | 1 |
| Ballester, M | 1 |
| Huguet, F | 1 |
| Chen, H | 3 |
| Liang, C | 1 |
| Zhang, L | 1 |
| Huang, S | 1 |
| Wu, X | 2 |
| Choi, CH | 2 |
| Song, SY | 1 |
| Choi, JJ | 1 |
| Park, YA | 1 |
| Kang, H | 1 |
| Kim, TJ | 2 |
| Lee, JW | 2 |
| Kim, BG | 2 |
| Lee, JH | 2 |
| Bae, DS | 2 |
| Terai, Y | 1 |
| Kanemura, M | 1 |
| Sasaki, H | 1 |
| Tsunetoh, S | 1 |
| Tanaka, Y | 1 |
| Yamashita, Y | 1 |
| Yamamoto, K | 2 |
| Narabayashi, I | 1 |
| Ohmichi, M | 1 |
| Moore, DH | 1 |
| Kumari, R | 1 |
| Sharma, A | 2 |
| Kang, YH | 3 |
| Lee, KA | 3 |
| Kim, JH | 2 |
| Park, SG | 1 |
| Yoon, DY | 3 |
| Pinheiro, W | 1 |
| Pereira, AK | 1 |
| Soares, JM | 1 |
| Baracat, EC | 1 |
| Liang, Y | 1 |
| Yashar, CM | 1 |
| Rose, BS | 1 |
| Cornell, M | 1 |
| Hoh, CK | 1 |
| Lawson, JD | 1 |
| Einck, J | 1 |
| Saenz, C | 1 |
| Fanta, P | 1 |
| Mundt, AJ | 1 |
| Bydder, GM | 1 |
| Nguyen, D | 1 |
| de la Rochefordière, A | 1 |
| Chauveinc, L | 1 |
| Cosset, JM | 1 |
| Clough, KB | 1 |
| Beuzeboc, P | 1 |
| Mouret-Fourme, E | 1 |
| Guyonnet, M | 1 |
| Lorvidhaya, V | 4 |
| Chitapanarux, I | 1 |
| Sangruchi, S | 1 |
| Lertsanguansinchai, P | 1 |
| Kongthanarat, Y | 1 |
| Tangkaratt, S | 1 |
| Visetsiri, E | 1 |
| Umeki, H | 1 |
| Yamaguchi, Y | 1 |
| Tsugata, M | 1 |
| Wakana, K | 1 |
| Somekawa, Y | 1 |
| Shimabukuro, K | 1 |
| Ohara, M | 1 |
| Terauchi, T | 1 |
| Ichimura, M | 1 |
| Otsuka, I | 1 |
| Aso, T | 1 |
| ISHIHARA, M | 1 |
| TERAO, S | 1 |
| HASHIGO, H | 1 |
| CENTARO, A | 1 |
| GASPARRI, F | 1 |
| MAIJNELLI, M | 1 |
| PERITI, P | 1 |
| IZUCHI, S | 1 |
| Petru, E | 1 |
| Benedicic, Ch | 1 |
| Seewann, A | 1 |
| Pickel, H | 3 |
| Seki, H | 1 |
| Takada, T | 1 |
| Sodemoto, T | 2 |
| Hoshino, H | 1 |
| Saitoh, K | 1 |
| Uekusa, T | 1 |
| Ivanov, S | 2 |
| Zervoudis, S | 1 |
| Takehara, M | 3 |
| Tanaka, R | 1 |
| Lee, R | 1 |
| Horie, M | 1 |
| Wataba, K | 1 |
| Ito, E | 2 |
| Kudo, R | 3 |
| Narayan, G | 1 |
| Arias-Pulido, H | 1 |
| Nandula, SV | 1 |
| Basso, K | 1 |
| Sugirtharaj, DD | 1 |
| Vargas, H | 1 |
| Mansukhani, M | 1 |
| Villella, J | 1 |
| Meyer, L | 1 |
| Schneider, A | 1 |
| Gissmann, L | 1 |
| Dürst, M | 1 |
| Pothuri, B | 1 |
| Murty, VV | 2 |
| Tabata, T | 1 |
| Nishiura, K | 1 |
| Yanoh, K | 1 |
| Okugawa, T | 1 |
| Obata, H | 1 |
| Tanaka, K | 1 |
| Toyoda, N | 1 |
| Umesaki, N | 4 |
| Fujii, T | 1 |
| Nishimura, R | 1 |
| Tanaka, T | 4 |
| Nishida, M | 1 |
| Fushiki, H | 3 |
| Takizawa, K | 3 |
| Hasegawa, K | 1 |
| Izumi, R | 3 |
| Terauchi, F | 1 |
| Katayama, H | 1 |
| Yamashita, T | 1 |
| Sengoku, K | 1 |
| Ishikawa, M | 1 |
| Hara, K | 3 |
| Motoyama, S | 1 |
| Hamana, S | 1 |
| Ku, Y | 1 |
| Laoag-Fernandez, JB | 1 |
| Deguchi, M | 1 |
| Yoshida, S | 2 |
| Tominaga, M | 1 |
| Iwasaki, T | 1 |
| Ohara, N | 1 |
| Maruo, T | 1 |
| Wang, P | 1 |
| Peng, ZL | 1 |
| Zhang, JW | 1 |
| Zhang, CS | 1 |
| Cao, ZY | 1 |
| Mizuno, K | 1 |
| Kidokoro, K | 1 |
| Miyazaki, K | 1 |
| Yoshida, K | 1 |
| Nakagawa, A | 1 |
| Mizuno, M | 1 |
| Suzuki, S | 1 |
| Kuno, N | 1 |
| Furuhashi, M | 1 |
| Ishizuka, T | 1 |
| Ishikawa, K | 1 |
| Ryu, CJ | 1 |
| Lee, HG | 1 |
| Lim, JS | 1 |
| Park, SN | 2 |
| Paik, SG | 2 |
| Windschall, A | 1 |
| Ott, OJ | 1 |
| Sauer, R | 1 |
| Strnad, V | 1 |
| Kobayashi, Y | 1 |
| Akiyama, F | 2 |
| Hasumi, K | 4 |
| Kokawa, K | 1 |
| Bai, T | 1 |
| Yukawa, K | 1 |
| Massard, C | 1 |
| Zermati, Y | 1 |
| Pauleau, AL | 1 |
| Larochette, N | 1 |
| Métivier, D | 1 |
| Sabatier, L | 1 |
| Kroemer, G | 1 |
| Soria, JC | 1 |
| Eifel, PJ | 2 |
| Takeshima, N | 1 |
| Umayahara, K | 1 |
| Fujiwara, K | 1 |
| Hirai, Y | 1 |
| Tanaka, H | 1 |
| Kihira, T | 1 |
| Nomura, Y | 1 |
| Ishihara, A | 1 |
| Sobotkowski, J | 1 |
| Markowska, J | 1 |
| Fijuth, J | 1 |
| Pietraszek, A | 1 |
| Yang, Y | 1 |
| Kim, SH | 1 |
| van Luijk, IF | 1 |
| Coens, C | 1 |
| van der Burg, ME | 2 |
| Kobierska, A | 1 |
| Namer, M | 1 |
| Lhomme, C | 1 |
| Zola, P | 3 |
| Zanetta, G | 1 |
| Vermorken, JB | 4 |
| Sakata, K | 1 |
| Sakurai, H | 1 |
| Suzuki, Y | 1 |
| Katoh, S | 1 |
| Ohno, T | 1 |
| Toita, T | 1 |
| Kataoka, M | 1 |
| Tanaka, E | 1 |
| Kaneyasu, Y | 5 |
| Uno, T | 1 |
| Harima, Y | 1 |
| Nakano, T | 1 |
| Boice, CR | 1 |
| Freedman, RS | 1 |
| Herson, J | 1 |
| Wharton, JT | 2 |
| Rutledge, FN | 1 |
| Tropé, C | 2 |
| Simonsen, E | 2 |
| Johnsson, JE | 2 |
| Sigurdsson, K | 2 |
| Stendahl, U | 1 |
| Mattsson, W | 1 |
| Gullberg, B | 1 |
| Copas, P | 1 |
| Dyer, M | 1 |
| Smithson, LG | 1 |
| Hall, DJ | 1 |
| Joselson, R | 1 |
| Warnock, M | 1 |
| Sekiba, K | 1 |
| Kohno, I | 1 |
| Saijo, N | 2 |
| Kawagoe, K | 2 |
| Iijima, S | 2 |
| Tsunoda, H | 1 |
| Sasaki, J | 2 |
| Inaba, J | 1 |
| Tokita, H | 1 |
| Tanaka, N | 1 |
| Ueno, T | 1 |
| Okamoto, K | 1 |
| Xu, ZD | 1 |
| Yajima, A | 2 |
| Abe, Y | 1 |
| Soh, K | 1 |
| Ozawa, N | 2 |
| Takabayashi, T | 2 |
| Sato, S | 1 |
| Uehara, S | 1 |
| Suzuki, M | 2 |
| Thomas, G | 1 |
| Dembo, A | 1 |
| Beale, F | 1 |
| Bean, H | 1 |
| Bush, R | 1 |
| Herman, J | 1 |
| Pringle, J | 1 |
| Rawlings, G | 2 |
| Sturgeon, J | 1 |
| Fine, S | 1 |
| Zhao, LR | 1 |
| Zhao, WX | 1 |
| Shao, MH | 1 |
| Hayakawa, O | 1 |
| Tonusin, A | 2 |
| Sukthomya, W | 1 |
| Changwiwit, W | 2 |
| Nimmolrat, A | 1 |
| Smith, HO | 1 |
| Stringer, CA | 1 |
| Kavanagh, JJ | 2 |
| Gershenson, DM | 1 |
| Edwards, CL | 1 |
| Thigpen, T | 1 |
| Blessing, JA | 1 |
| Gallup, DG | 1 |
| Maiman, M | 1 |
| Soper, JT | 1 |
| Matsuo, N | 2 |
| Yamasaki, F | 1 |
| Mvula, M | 1 |
| Sugimori, H | 5 |
| Tamada, T | 1 |
| Hayase, R | 1 |
| Seki, A | 1 |
| Yamamoto, J | 1 |
| Kodama, J | 2 |
| Yoshinouchi, M | 2 |
| Kobashi, Y | 2 |
| Okuda, H | 2 |
| Kudo, T | 2 |
| Trinci, M | 1 |
| Raffetto, N | 1 |
| Salvatori, F | 1 |
| Trinci, C | 1 |
| Denehy, TR | 1 |
| Eastman, R | 1 |
| SanFilippo, L | 1 |
| Gregori, CA | 1 |
| Breen, JL | 1 |
| John, M | 4 |
| Flam, M | 4 |
| Caplan, R | 1 |
| Rotman, M | 2 |
| Quivey, J | 1 |
| Steinfeld, A | 1 |
| Russell, A | 1 |
| Christie, DR | 1 |
| Bull, CA | 1 |
| Gebski, V | 1 |
| Langlands, AO | 2 |
| Okawa, MK | 3 |
| Kokubo, N | 2 |
| Takemoto, M | 1 |
| Karasawa, K | 3 |
| Fukuhara, N | 2 |
| Toda, J | 3 |
| Okawa, T | 4 |
| Takeda, S | 1 |
| Ikeba, K | 1 |
| Ohokubo, T | 1 |
| Yamamoto, T | 1 |
| Takagi, A | 1 |
| Hayashi, N | 1 |
| Kinoshita, K | 1 |
| Butz, K | 2 |
| Geisen, C | 2 |
| Ullmann, A | 2 |
| Spitkovsky, D | 1 |
| Hoppe-Seyler, F | 2 |
| Matsui, R | 1 |
| Kashihara, K | 1 |
| Higashi, T | 1 |
| Seo, K | 1 |
| Taoka, Y | 1 |
| Nishitani, H | 1 |
| Takegawa, Y | 1 |
| Hukumura, Y | 1 |
| Shimizu, Y | 5 |
| Amano, M | 1 |
| Kato, T | 1 |
| Rakovitch, E | 1 |
| Fyles, AW | 1 |
| Pintilie, M | 1 |
| Leung, PM | 1 |
| Hidaka, T | 2 |
| Hori, S | 2 |
| Fujimura, M | 2 |
| Yamakawa, Y | 3 |
| Umezawa, S | 1 |
| Ishiya, T | 1 |
| Utsugi, K | 1 |
| Nakano, H | 1 |
| Fukuda, K | 2 |
| Uchiyama, M | 1 |
| Konishi, I | 1 |
| Nanbu, K | 1 |
| Mandai, M | 1 |
| Tsuruta, Y | 1 |
| Kataoka, N | 1 |
| Nagata, Y | 2 |
| Mori, T | 2 |
| Ikuhashi, H | 1 |
| Hongo, A | 1 |
| Mizutani, Y | 1 |
| Miyagi, Y | 1 |
| Whitaker, N | 1 |
| Denk, C | 1 |
| Mantovani, F | 1 |
| Banks, L | 1 |
| Kilic, G | 1 |
| Cardillo, M | 1 |
| Ozdemirli, M | 1 |
| Arun, B | 1 |
| Kita, M | 1 |
| Katsui, K | 1 |
| Kono, M | 1 |
| Kojima, N | 1 |
| Himei, K | 1 |
| Isobe, M | 1 |
| Yamanouchi, E | 1 |
| Usuki, N | 1 |
| Hirokawa, K | 1 |
| Tashiro, T | 1 |
| Saiwai, S | 1 |
| Miyamoto, T | 1 |
| Ochiai, K | 1 |
| Saito, S | 1 |
| Mikami, M | 1 |
| Ezawa, S | 1 |
| Sakaiya, N | 1 |
| Komuro, Y | 1 |
| Tei, C | 1 |
| Fukuchi, T | 1 |
| Mukai, M | 1 |
| Favalli, G | 1 |
| Vantongelen, K | 1 |
| Renard, J | 1 |
| Van Oosterom, AT | 3 |
| Pecorelli, S | 3 |
| Nishioka, Y | 1 |
| Baba, T | 1 |
| Suzuki, T | 1 |
| Durand, RE | 1 |
| LePard, NE | 1 |
| Roberts, KB | 1 |
| Urdaneta, N | 1 |
| Vera, R | 1 |
| Vera, A | 1 |
| Gutierrez, E | 1 |
| Aguilar, Y | 1 |
| Ott, S | 1 |
| Medina, I | 1 |
| Sempere, P | 1 |
| Rockwell, S | 1 |
| Sartorelli, AC | 1 |
| Fischer, DB | 1 |
| Fischer, JJ | 1 |
| Shigematsu, T | 1 |
| Ohishi, Y | 1 |
| Fujita, T | 1 |
| Higashihara, J | 1 |
| Irie, T | 1 |
| Hayashi, T | 1 |
| Huang, TG | 1 |
| Ip, SM | 1 |
| Yeung, WS | 1 |
| Ngan, HY | 1 |
| Wagenaar, HC | 1 |
| Mangioni, C | 2 |
| Rotmensz, N | 1 |
| Anastasopoulou, A | 1 |
| Veenhof, CH | 1 |
| Lacave, AJ | 1 |
| Neijt, JP | 1 |
| Einhorn, N | 1 |
| Minagawa, Y | 1 |
| Onohara, Y | 1 |
| Takahashi, H | 1 |
| Tsudo, T | 1 |
| Dunst, J | 1 |
| Haensgen, G | 1 |
| Berclaz, G | 1 |
| Gerber, E | 1 |
| Beer, K | 1 |
| Aebi, S | 1 |
| Greiner, R | 1 |
| Dreher, E | 1 |
| Buser, K | 1 |
| Miya, T | 1 |
| Sasaki, Y | 1 |
| Karato, A | 1 |
| Itoh, N | 1 |
| Sawairi, M | 1 |
| Hanabayashi, T | 1 |
| Mori, H | 1 |
| Yamawaki, Y | 1 |
| Tamaya, T | 1 |
| Wheelock, JB | 1 |
| Krebs, HB | 1 |
| Goplerud, DR | 1 |
| Hoffman, MS | 1 |
| Roberts, WS | 1 |
| LaPolla, JP | 1 |
| Fiorica, JV | 1 |
| Hewitt, S | 1 |
| Cavanagh, D | 1 |
| Souhami, L | 1 |
| Gil, RA | 1 |
| Allan, SE | 1 |
| Canary, PC | 1 |
| Araújo, CM | 1 |
| Pinto, LH | 1 |
| Silveira, TR | 1 |
| Nakayama, K | 1 |
| Seimiya, Y | 1 |
| Koi, S | 1 |
| Yokosuka, K | 1 |
| Teshima, H | 1 |
| Chen, JT | 1 |
| Fujimoto, I | 2 |
| Yamauchi, K | 1 |
| Masubuchi, K | 1 |
| Nguyen, PD | 1 |
| John, B | 1 |
| Munoz, AK | 1 |
| Yazigi, R | 1 |
| Graham, M | 1 |
| Franklin, P | 1 |
| Yamagishi, M | 1 |
| Khoury, GG | 1 |
| Bulman, AS | 1 |
| Joslin, CA | 1 |
| Rothwell, RI | 1 |
| Deppe, G | 4 |
| Malviya, VK | 4 |
| Han, I | 1 |
| Christensen, CW | 1 |
| Malone, JM | 1 |
| Kim, Y | 2 |
| Ahmad, K | 1 |
| Nagasawa, M | 1 |
| Ishii, S | 1 |
| Kariya, Y | 1 |
| Itoh, O | 1 |
| Yamamoto, H | 1 |
| Kawaharajo, K | 1 |
| Takeuchi, T | 1 |
| Sikic, B | 1 |
| Cooper, J | 1 |
| Malec, M | 1 |
| Hannigan, J | 1 |
| Phillips, T | 1 |
| Kinashi, Y | 1 |
| Abe, M | 1 |
| Honda, T | 1 |
| Takai, I | 1 |
| Tai, S | 1 |
| Meanwell, CA | 1 |
| Luesley, DM | 1 |
| Blackledge, G | 1 |
| Mould, JJ | 1 |
| Chan, KK | 1 |
| Perren, TJ | 1 |
| Lawton, FG | 1 |
| Yasui, Y | 1 |
| Suzumori, K | 1 |
| Asai, H | 1 |
| Yagami, Y | 1 |
| vd Burg, ME | 1 |
| Subandono, AJ | 1 |
| De Oliveira, CF | 1 |
| van Lindert, AC | 1 |
| Singh, P | 1 |
| Dharmalingam, SK | 1 |
| Tan, MK | 1 |
| Tan, CK | 1 |
| Giannone, L | 1 |
| Brenner, DE | 1 |
| Jones, HW | 1 |
| Greco, FA | 1 |
| Burnett, LS | 1 |
| Chander, S | 2 |
| Ghosh, D | 2 |
| Aggarwal, N | 2 |
| Lahousen, M | 2 |
| Tamussino, K | 1 |
| Kawabata, M | 1 |
| Hosokawa, H | 1 |
| Katoh, K | 1 |
| Alberts, DS | 2 |
| Kronmal, R | 1 |
| Baker, LH | 1 |
| Stock-Novack, DL | 1 |
| Surwit, EA | 2 |
| Boutselis, JG | 1 |
| Hannigan, EV | 1 |
| Lipsztein, R | 1 |
| Kredentser, D | 1 |
| Dottino, P | 1 |
| Goodman, HM | 1 |
| Dalton, JF | 1 |
| Bloomer, WD | 1 |
| Cohen, C | 1 |
| Yokoyama, T | 1 |
| Kaneko, H | 1 |
| Yorishima, M | 1 |
| Tanaka, M | 1 |
| Chiba, T | 1 |
| Weiner, SA | 1 |
| Aristizabal, S | 1 |
| Deatherage-Deuser, K | 1 |
| Lejarcegui, JA | 1 |
| Cot, X | 1 |
| Lailla, JM | 1 |
| Tarrats, A | 1 |
| Davi, E | 1 |
| Ausin, J | 1 |
| Marquez, M | 1 |
| Jou, P | 1 |
| Guix, B | 1 |
| Gonzales-Merlo, J | 1 |
| Asins, E | 1 |
| Aznar, I | 1 |
| Bernabeu, JR | 1 |
| Lonjedo, L | 1 |
| Ruiz, F | 1 |
| Viñas, T | 1 |
| Gresa, M | 1 |
| Llixiona, J | 1 |
| Galbis, M | 1 |
| Chambers, SK | 1 |
| Flynn, SD | 1 |
| Del Prete, SA | 1 |
| Chambers, JT | 1 |
| Schwartz, PE | 1 |
| Lele, SB | 1 |
| Piver, MS | 1 |
| Hayashi, Y | 1 |
| Hachisuga, T | 1 |
| Haas, H | 1 |
| Sivanesaratnam, V | 2 |
| Jayalakshmi, P | 1 |
| Yokota, K | 2 |
| Ueda, K | 2 |
| Ohama, K | 2 |
| Fujiwara, A | 2 |
| Senapad, S | 2 |
| Neungton, S | 1 |
| Usavajindawath, C | 1 |
| Vijatrasil, S | 1 |
| Thaithanaisawanya, V | 1 |
| Gove, N | 2 |
| Schoenmaker, M | 1 |
| Coffman, FD | 1 |
| Green, LM | 1 |
| Godwin, A | 1 |
| Ware, CF | 1 |
| Belinson, JL | 1 |
| Stewart, JA | 1 |
| Richards, AL | 1 |
| McClure, M | 1 |
| Punpae, P | 1 |
| Charoeniam, V | 1 |
| Ployleumsang, D | 1 |
| Issariyodom, P | 1 |
| Young, JD | 1 |
| Boike, G | 1 |
| Wittlinger, P | 1 |
| Podolsky, W | 1 |
| Padmanabhan, A | 2 |
| Mowry, PA | 2 |
| Sou, S | 1 |
| Sho, K | 1 |
| Sasamoto, K | 1 |
| Takenaka, M | 1 |
| Mitra, AB | 1 |
| Das, BC | 1 |
| Luthra, UK | 1 |
| Ino, Y | 1 |
| Isono, T | 1 |
| Sato, M | 1 |
| Iguchi, T | 1 |
| Takeda, Y | 1 |
| Thomas, GM | 1 |
| Dembo, AJ | 1 |
| Black, B | 1 |
| Bean, HA | 1 |
| Beale, FA | 1 |
| Pringle, JR | 1 |
| Depetrillo, D | 1 |
| Cooke, JK | 1 |
| Jian, S | 1 |
| Ludgate, SM | 1 |
| Crandon, AJ | 1 |
| Hudson, CN | 1 |
| Walker, Q | 1 |
| Evans, LS | 1 |
| Kersh, CR | 1 |
| Constable, WC | 1 |
| Taylor, PT | 1 |
| Guthrie, D | 1 |
| Ikeda, K | 1 |
| Ogawa, M | 1 |
| Inagaki, J | 1 |
| Horikoshi, N | 1 |
| Inoue, K | 1 |
| Usui, N | 1 |
| Nakada, H | 1 |
| Adachi, K | 1 |
| Yamazaki, H | 1 |
| Tada, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| To Study the Factors Affecting Treatment Responses in Patients With Uterine Cervical Carcinoma Undergoing Neoadjuvant Chemotherapy[NCT05384366] | Phase 3 | 33 participants (Actual) | Interventional | 2020-08-01 | Completed | ||
| Phase II Trial To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix[NCT04789941] | Phase 2 | 50 participants (Anticipated) | Interventional | 2021-04-01 | Not yet recruiting | ||
| Prospective Study for the Validation of the Genetic Signature 354849 to Predict the Response to Standard Treatment in Patients With Locally Advanced Cervical Cancer[NCT04067882] | 189 participants (Anticipated) | Observational | 2019-09-30 | Recruiting | |||
| COnventional Radiography Based Intracavitary Brachytherapy (Standard Arm) Versus Magnetic Resonance Image Based BrAchyTherapy (Study Arm) in Locally Advanced Cervical Cancers: A Phase III Randomized Controlled Trial (COMBAT - Cervix Trial)[NCT03005743] | 1,050 participants (Anticipated) | Interventional | 2016-12-31 | Recruiting | |||
| Randomized Controlled Trial of the Efficacy of Adjuvant Chemotherapy in Patients With Residual Lesions After Concurrent Radiochemotherapy for Locally Advanced Cervical Cancer[NCT04409860] | 120 participants (Anticipated) | Interventional | 2020-05-26 | Recruiting | |||
| Effect of a Low Residue Diet in Comparison to the Dietary Recommendations From the INCan: A Randomized Clinical Trial to Assess Malnutrition, Gastrointestinal Toxicity and Quality of Life of Advanced Cervical Cancer Patients (IB2-IVA)[NCT03100409] | 137 participants (Actual) | Interventional | 2017-02-01 | Terminated (stopped due to The study was closed prematurely because the interim analysis found that subjects in the experimental group had less gastrointestinal toxicity.) | |||
| Multicenter Prospective Randomized Study on NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Patients With Cervical Cancer FIGO Stage IB2 and IIB[NCT02422563] | Phase 3 | 534 participants (Anticipated) | Interventional | 2015-10-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
18 reviews available for mitomycin and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin | 2014 |
Combined chemotherapy and radiation therapy for cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase III as Topic; Comb | 2004 |
Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Fluoro | 2010 |
Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Fluoro | 2010 |
Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Fluoro | 2010 |
Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Fluoro | 2010 |
[Neoadjuvant intraarterial chemotherapy with nedaplatin, peplomycin and mitomycin C for advanced cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administra | 2003 |
Palliative cytostatic treatment of cervical carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Camptothecin; Carcinoma, Squamous Cell; C | 2003 |
[Irinotecan hydrochloride (CPT-11) for advanced cervical cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Car | 2004 |
[BOMP (BLM, VCR, MMC, and CDDP) therapy for advanced cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Comb | 2004 |
[Chemotherapy with mitomycin C, etoposide and cisplatin for adenocarcinoma of the uterine cervix].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; E | 2004 |
Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer.
Topics: Antineoplastic Agents; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Epirubicin; Fema | 2006 |
Bolus mitomycin C and 5-FU with sequential radiation for poor-prognosis locally advanced cervical cancer.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma; Combined Modality Therapy; | 1996 |
[Consecutive low-dose cisplatin-based chemotherapy for gynecologic malignancies].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; | 1997 |
[Clinical evaluation of chemoradiotherapy for advanced cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug | 1997 |
[Gynecologic cancer-evidenced based chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Evidence-Based Medicine; Femal | 2000 |
Chemotherapy of advanced or recurrent cervical carcinoma with a consecutive low-dose cisplatin combined with bleomycin, vincristine, and mitomycin-C (consecutive low-dose BOMP).
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleo | 2000 |
Chemoradiation for carcinoma of the cervix: advances and opportunities.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, A | 2000 |
Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineop | 2001 |
[Perspectives and plans to improve the prognosis of cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Fem | 1990 |
Chemotherapy of cervical cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as | 1985 |
39 trials available for mitomycin and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carcinoma, Sq | 2013 |
Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carcinoma, Sq | 2013 |
Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carcinoma, Sq | 2013 |
Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carcinoma, Sq | 2013 |
A clinical Comparison of Lobaplatin or Cisplatin with Mitomycine and Vincristine in Treating Patients with Cervical Squamous Carcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; | 2015 |
Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Fema | 2008 |
Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Di | 2008 |
Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B | 2003 |
Phase II study of irinotecan combined with mitomycin-C for advanced or recurrent squamous cell carcinoma of the uterine cervix: the JGOG study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; | 2004 |
Neoadjuvant high-dose intraarterial infusion chemotherapy under percutaneous pelvic perfusion with extracorporeal chemofiltration in patients with stages IIIa-IVa cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusio | 2004 |
[Comparison of therapeutical effect between arterial interventional chemotherapy and venous chemotherapy on bulky or locally advanced cervical cancer].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans; Inje | 2005 |
[Neoadjuvant chemotherapy with intra-arterial infusion in the treatment of advanced cervical cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Ch | 2005 |
Preoperative chemotherapy with irinotecan and mitomycin for FIGO stage IIIb cervical squamous cell carcinoma: a pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Squamous Cell; | 2005 |
Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Hysterectomy | 2007 |
Salvage chemotherapy with a combination of irinotecan hydrochloride and mitomycin C in elderly Japanese patients with gynecological malignancies: a pilot study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Female; Human | 2006 |
Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Ci | 2007 |
Bleomycin and mitomycin-C (BLM-M) in recurrent squamous uterine cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carci | 1982 |
Radio chemotherapy in carcinoma of the cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Fe | 1995 |
Induction chemotherapy and irradiation in advanced carcinoma of the cervix.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined M | 1995 |
Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Ci | 1993 |
Phase II trial of mitomycin-C in squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Humans; Middle Aged; Mitomycin; Prognosis; Uterine Ce | 1995 |
[Combination chemotherapy of peplomycin, vincristine, mitomycin C, and cisplatin in gynecologic carcinomas].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Genital Neoplasms, F | 1994 |
Bolus mitomycin C and 5-FU with sequential radiation for poor-prognosis locally advanced cervical cancer.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Carcinoma; Combined Modality Therapy; | 1996 |
Final results of a phase II chemoradiation protocol for locally advanced cervical cancer: RTOG 85-15.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; C | 1996 |
[Clinical evaluation of intra-arterial infusion chemotherapy for advanced or recurrent pelvic tumors with or without radiotherapy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplati | 1996 |
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; | 1996 |
[Usefulness of MR imaging in evaluating and predicting effect of neoadjuvant chemotherapy on uterine cervical carcinoma].
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcin | 1997 |
[Clinical evaluation of intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamou | 1997 |
[Effectiveness of 3 ways method in intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedu | 1999 |
Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 2000 |
Quality control in multicentric clinical trials. An experience of the EORTC Gynecological Cancer Cooperative Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Protocols; Data Colle | 2000 |
Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix.
Topics: Actuarial Analysis; Adult; Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Chemotherapy, Adju | 2000 |
Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Fe | 2001 |
A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin | 1991 |
[Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Ci | 1991 |
Mitomycin-C/5-FU and radiation therapy for locally advanced uterine cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality T | 1991 |
Concomitant pelvic irradiation, 5-fluorouracil and mitomycin C in the treatment of advanced cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Flu | 1991 |
Preliminary results of concurrent radiotherapy and chemotherapy in advanced cervical carcinoma: a phase I-II prospective intergroup NCOG-RTOG Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Combined Moda | 1990 |
Chemotherapy-radiotherapy combination in the treatment of carcinoma of the cervix.
Topics: Adult; Aged; Bleomycin; Carcinoma; Combined Modality Therapy; Female; Humans; Middle Aged; Mitomycin | 1985 |
Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Ci | 1987 |
A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 1988 |
Chemotherapy of cervical cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as | 1985 |
121 other studies available for mitomycin and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Synthesis and structure-activity relationship study of lamellarin derivatives.
Topics: Alkaloids; Animals; Chlorocebus aethiops; Coumarins; Dogs; Drug Screening Assays, Antitumor; Female; | 2002 |
Design and synthesis of harzialactone analogues: promising anticancer agents.
Topics: 4-Butyrolactone; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Drug Design; Drug Scree | 2010 |
Neferine Enhances the Antitumor Effect of Mitomycin-C in Hela Cells Through the Activation of p38-MAPK Pathway.
Topics: Antineoplastic Agents; Benzylisoquinolines; Female; HeLa Cells; Humans; MAP Kinase Signaling System; | 2017 |
Preoperative Chemoradiotherapy in Locally Advanced Bulky Squamous Cell Carcinoma of the Uterine Cervix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Chem | 2017 |
Piperine (PP) enhanced mitomycin-C (MMC) therapy of human cervical cancer through suppressing Bcl-2 signaling pathway via inactivating STAT3/NF-κB.
Topics: Alkaloids; Animals; Apoptosis; Benzodioxoles; Cell Line, Tumor; Cell Proliferation; Drug Resistance, | 2017 |
Antineoplastic activity of mitomycin C formulated in nanoemulsions-based essential oils on HeLa cervical cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Nucleus; Cell Shape; DNA; Emulsions; Female; HeLa Cells; Huma | 2018 |
Cytotoxicity and apoptosis enhancement in breast and cervical cancer cells upon coadministration of mitomycin C and essential oils in nanoemulsion formulations.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Proliferation; Cel | 2018 |
Neoadjuvant intra-arterial chemotherapy followed by total laparoscopic radical trachelectomy in stage IB1 cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Female; Humans; Injecti | 2014 |
Fat composition changes in bone marrow during chemotherapy and radiation therapy.
Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Co | 2014 |
Self-Assembled Nanoparticles Based on Amphiphilic Anticancer Drug-Phospholipid Complex for Targeted Drug Delivery and Intracellular Dual-Controlled Release.
Topics: Animals; Antineoplastic Agents; Cell Survival; Drug Carriers; Drug Liberation; Female; Folic Acid; H | 2015 |
Proteasomal inhibition sensitizes cervical cancer cells to mitomycin C-induced bystander effect: the role of tumor microenvironment.
Topics: Animals; Bystander Effect; Cell Proliferation; Fas Ligand Protein; Female; Gene Expression Regulatio | 2015 |
[Stage IB2, IIA and IIB cervical carcinoma without lymph node extension treated with neoadjuvant chemoradiotherapy].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; C | 2016 |
Long-term follow-up of neoadjuvant intraarterial chemotherapy using an original four-lumen double-balloon (4L-DB) catheter for locally advanced uterine cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Catheterizati | 2009 |
Mitomycin C induces bystander killing in homogeneous and heterogeneous hepatoma cellular models.
Topics: Bystander Effect; Carcinoma, Hepatocellular; Cell Count; Cell Death; Cell Line, Tumor; Cell Membrane | 2009 |
Mitomycin C modulates DNA-double strand break repair genes in cervical carcinoma cells.
Topics: Carcinoma, Squamous Cell; DNA; DNA Breaks, Double-Stranded; DNA Repair; Female; Humans; Mitomycin; T | 2010 |
Is the combination of mitomycin C, bleomycin and methotrexate effective as a neoadjuvant treatment for cervical cancer in women?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Female; Humans; Methotrexate | 2011 |
Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies.
Topics: Adipose Tissue; Adult; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Marrow; | 2013 |
[Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998]].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Comb | 2002 |
[DRUG THERAPY OF UTERINE CANCER].
Topics: Antineoplastic Agents; Azaguanine; Blood Chemical Analysis; Catalase; Clinical Enzyme Tests; Deoxyri | 1964 |
[PRESENT POSSIBILITIES OF CHEMOPROPHYLAXIS, COMPLEMENTARY AND PALLIATIVE CHEMOTHERAPY IN ASSOCIATION WITH SURGERY IN THE TREATMENT OF UTERINE NEOPLASMS].
Topics: Adenocarcinoma; Antineoplastic Agents; Aziridines; Chemoprevention; Female; Fluorouracil; Humans; Mi | 1964 |
[STUDIES ON CONTINUOUS INTRA-HYPOGASTRIC ARTERIAL INFUSION OF ANTICARCINOGENIC AGENTS IN PATIENTS WITH CERVICAL CANCER AS A SUPPLEMENTARY THERAPY TO SURGICAL OPERATION].
Topics: Anticarcinogenic Agents; Cyclophosphamide; Dogs; Drug Therapy; Female; Humans; Infusions, Intra-Arte | 1964 |
A young woman with clear cell adenocarcinoma of the uterine cervix.
Topics: Adenocarcinoma, Clear Cell; Adolescent; Age of Onset; Antineoplastic Combined Chemotherapy Protocols | 2003 |
[Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a stage I B and II A cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Etoposide; Fema | 2003 |
Correlation between responsiveness of neoadjuvant chemotherapy and apoptosis-associated proteins for cervical adenocarcinoma.
Topics: Aclarubicin; Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; | 2004 |
Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer.
Topics: Alkylating Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Chromosomes, Human; DNA Methylation; | 2004 |
A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Comb | 2004 |
Mitomycin C induces apoptosis via Fas/FasL dependent pathway and suppression of IL-18 in cervical carcinoma cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 8; Caspases; Cell | 2006 |
Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; An | 2005 |
Effects of mitomycin C on radiation-induced cell death in human cervical squamous cell carcinomas.
Topics: Antibiotics, Antineoplastic; Carcinoma, Squamous Cell; Cell Death; Cell Line, Tumor; Combined Modali | 2005 |
A case of successful pregnancy after treatment of invasive cervical cancer with systemic chemotherapy and conization.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Thera | 2006 |
Optimal combination chemotherapy and chemoradiotherapy with etoposide for advanced cervical squamous cancer cells in vitro.
Topics: Antigens, CD20; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Squamous Cell; CD40 Anti | 2006 |
hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Catalytic Domain; Cell Line, Tumor; Ce | 2006 |
Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Adenosquamous; Ca | 2006 |
Preliminary results of mitomycin C local application as post-treatment prevention of vaginal radiation-induced morbidity in women with cervical cancer.
Topics: Antibiotics, Antineoplastic; Brachytherapy; Female; Humans; Iridium Radioisotopes; Middle Aged; Mito | 2006 |
The apoptotic effect of intercalating agents on HPV-negative cervical cancer C-33A cells.
Topics: Apoptosis; Blotting, Western; Carboplatin; Caspases; Cell Proliferation; Cisplatin; Enzyme-Linked Im | 2007 |
Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy | 2008 |
[Bleomycin combined with mitomycin C in recurrent cervix cancer].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Bleomycin; Drug Therapy, Combination; Female; Humans; Midd | 1982 |
Bleomycin-mitomycin C in advanced carcinoma of the cervix. A third look.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Bleomycin; Carcinoma, Squamous Cell; Drug Therapy, Combina | 1983 |
Bleomycin-mitomycin C in advanced squamous cell carcinoma of the female genital tract.
Topics: Adult; Aged; Bleomycin; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; Genital Neoplas | 1983 |
Pulmonary veno-occlusive disease after chemotherapy.
Topics: Adult; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Cystitis; Female; Humans; Lung; Mitomycin; Mi | 1983 |
[Problems in the treatment of cervical carcinoma].
Topics: Aged; Bleomycin; Female; Humans; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Uterine Cervical | 1983 |
[Chemotherapy against pulmonary metastasis from uterine cervical carcinoma].
Topics: Antineoplastic Agents; Carbazilquinone; Dextran Sulfate; Dextrans; Drug Therapy, Combination; Female | 1982 |
[Intra-arterial infusion of oncostatics in recurrent cervical carcinoma].
Topics: Antineoplastic Agents; Bleomycin; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Humans; | 1983 |
Recurrent cervical cancer in the pelvis--intra-arterial infusion of oncostatics.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Catheterization; Cisplatin; Combined Moda | 1983 |
[Cytomorphological effect of anticancer drugs on human solid tumors in nude mice--time response].
Topics: Animals; Antineoplastic Agents; Bleomycin; Cell Nucleus; Cytoplasm; Female; Humans; Mice; Mice, Nude | 1983 |
Effects of radiotherapy and chemotherapy on sister chromatid exchanges in peripheral lymphocytes of the patients with gynecologic cancer.
Topics: Choriocarcinoma; Crossing Over, Genetic; Female; Genital Neoplasms, Female; Humans; Lymphocytes; Mit | 1983 |
Concurrent radiation, mitomycin C and 5-fluorouracil in poor prognosis carcinoma of cervix: preliminary results of a phase I-II study.
Topics: Antibiotics, Antineoplastic; Brachytherapy; Carcinoma, Squamous Cell; Cesium Radioisotopes; Combined | 1984 |
[Treatment of advanced and recurrent gynecologic cancer with chemotherapy by cannula perfusion into both internal iliac arteries].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Ci | 1994 |
[Experimental and clinical study on chemotherapy for cervical adenocarcinoma].
Topics: Aclarubicin; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squ | 1995 |
Effects of single and combined application of anti-cancer drugs on cervical adenocarcinoma. I. Antitumor activity in vitro.
Topics: Adenocarcinoma; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Combined | 1995 |
[Loco-regional intra-arterial chemotherapy combined with radiotherapy in cervical carcinoma].
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Infusions, Intra-Arterial; Mito | 1993 |
Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brac | 1995 |
Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents: repression of E6/E7-oncogene expression and induction of apoptosis.
Topics: Apoptosis; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Damage; DNA-Binding Protei | 1996 |
[A case of recurrent squamous cell carcinoma of cervix successfully treated with BOMP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Fema | 1996 |
Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix.
Topics: Adenocarcinoma; Adenocarcinoma, Clear Cell; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplas | 1997 |
[Evaluation of a new anti-cancer drug regimen against uterine cervical cancer in nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Camptothecin; Ca | 1997 |
Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin | 1998 |
Adjuvant chemotherapy after radical hysterectomy for cervical carcinoma: a comparison with effects of adjuvant radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; | 1998 |
Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamou | 1998 |
Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Membe | 1998 |
[Neoadjuvant chemotherapy for advanced cervical cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamou | 1999 |
Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Topics: Carcinoma; Cell Division; Cisplatin; DNA Damage; Female; GADD45 Proteins; Gamma Rays; Gene Expressio | 1999 |
Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines.
Topics: Acetylcysteine; Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma; C | 1999 |
Human papillomavirus 18 oncoproteins E6 and E7 enhance irradiation- and chemotherapeutic agent-induced apoptosis in p53 and Rb mutated cervical cancer cell lines.
Topics: Apoptosis; DNA-Binding Proteins; Female; Genes, p53; Genes, Retinoblastoma; Humans; Mitomycin; Oncog | 1999 |
[Intraarterial chemotherapy for uterine cervical adenocarcinoma: evaluation of its efficacy as neoadjuvant therapy].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cel | 1999 |
Response of glassy-cell carcinoma of the cervix to cisplatin, epirubicin, and mitomycin C.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Epirubic | 2000 |
A case of stage-IVb cervical adenocarcinoma successfully treated by combination chemotherapy: case report.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Adminis | 2000 |
Effects of mitomycin C on the oxygenation and radiosensitivity of murine and human tumours in mice.
Topics: Animals; Apoptosis; Cervix Uteri; Colon; Colonic Neoplasms; Disease Models, Animal; Female; Humans; | 2000 |
Metastatic carcinoma in a transposed ovary after radical hysterectomy for a stage 1B cervical adenosquamous cell carcinoma. Case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Etoposid | 2000 |
Mitomycin C and cisplatin enhanced the antitumor activity of p53-expressing adenovirus in cervical cancer cells.
Topics: Adenoviruses, Human; Antineoplastic Agents, Alkylating; Apoptosis; Bone Neoplasms; Carcinoma, Squamo | 2001 |
Blood flow after intraarterial infusion chemotherapy in a patient with advanced cervical cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arteries; Chemotherapy, Adjuvant; Cisplatin; Female; | 2001 |
[Study on the reversion of drug resistance in human cervical cancer cell lines].
Topics: Animals; Antibiotics, Antineoplastic; Cyclosporins; Disease Models, Animal; Drug Resistance, Neoplas | 2001 |
Long-term follow-up of concurrent radiotherapy and chemotherapy for locally advanced cervical cancer: 12-Year survival after radiochemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Female; Fluoro | 2002 |
Pharmacokinetic study of mitomycin C with emphasis on the influence of aging.
Topics: Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; | 1992 |
Neoadjuvant intraarterial infusion chemotherapy with a combination of mitomycin-C, vincristine, and cisplatin for locally advanced cervical cancer: a preliminary report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Female; Hum | 1992 |
[Characterization of two novel cell lines established from a single human uterine cervical adenocarcinoma, and their chemosensitivities and hormonal effects on their proliferation].
Topics: Adenocarcinoma; Animals; Carbazilquinone; Cell Division; Drug Screening Assays, Antitumor; Estradiol | 1992 |
Bleomycin, vincristine, and mitomycin C (BOM) as second-line treatment after failure of cis-platinum-based combination chemotherapy for recurrent cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Female; Humans; M | 1990 |
A phase II evaluation of cisplatin, bleomycin, and mitomycin-C in patients with recurrent squamous cell carcinoma of the cervix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplati | 1991 |
[Intraarterial combination chemotherapy consisting of bleomycin, vincristine, mitomycin-C, and cisplatin (BOMP) for cervical cancer recurrence in the pelvis].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Administrati | 1991 |
[Studies on chemotherapy in adenocarcinoma of the uterine cervix using xenografts transplanted in nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cyclophospha | 1991 |
A preliminary report of combination chemotherapy with cisplatin and mitomycin-C followed by radical hysterectomy or radiation therapy in patients with locally advanced cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; F | 1991 |
[In vitro combined effects of pirarubicin (THP) and various antitumor drugs on human tumor cell lines].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Dr | 1990 |
[Transcatheter intra-arterial injection of combination drugs in case of advanced uterine cervical cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Do | 1990 |
Assessment of bleomycin, adriamycin and mitomycin-C in the treatment of recurrent cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Do | 1985 |
[Combination chemotherapy with peplomycin, cis-platinum and mitomycin C in gynecologic cancer].
Topics: Adenocarcinoma; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; | 1985 |
Vincristine, bleomycin, mitomycin C, cisplatin combination chemotherapy as additive treatment to radiotherapy in poor risk patients with squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Ci | 1985 |
Combination chemotherapy for patients with advanced carcinoma of the cervix: trial of mitomycin-C, vincristine, bleomycin, and cisplatin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Female; Follow-Up | 1987 |
Combination chemotherapy in the treatment of advanced squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Fe | 1986 |
Adjuvant combination chemotherapy in the treatment of advanced cancer of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Co | 1985 |
Chemotherapy for advanced and/or recurrent cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Ci | 1987 |
[Sensitivity of antineoplastic agents in squamous cell carcinoma of the uterine cervix xenografted into nude mice].
Topics: Animals; Antineoplastic Agents; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Sc | 1987 |
Combined chemotherapy and radiation therapy for advanced carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Ci | 1987 |
[Clinical effect of combination chemotherapy with peplomycin and mitomycin C (PM therapy) in recurrent uterine cervical cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Female; Humans; Infusions, Intraven | 1988 |
Intraarterial infusion chemotherapy as a primary treatment in cancer of uterine cervix limited to the pelvis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Female; Humans; I | 1988 |
[Chemotherapy of advanced cervical carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Female; Humans; M | 1985 |
Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Ci | 1989 |
Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1989 |
Treatment of advanced cervical cancer by a combination of peplomycin, vincristine, mitomycin-C, and cisplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Female; Follow-Up Studies; Hum | 1989 |
[Adjuvant chemotherapy in radical surgery of cervix cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Fem | 1989 |
Mitomycin C adjuvant chemotherapy after Wertheim's hysterectomy for stage IB cervical cancer.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Follow-Up Studies; Huma | 1989 |
Mitomycin-C cardiotoxicity.
Topics: Carcinoma, Squamous Cell; Female; Heart Failure; Humans; Middle Aged; Mitomycin; Mitomycins; Uterine | 1989 |
Increased spontaneous and mitomycin C-induced sister chromatid exchanges in patients with cancer of the cervix uteri, with special reference to stage of cancer.
Topics: Adult; Age Factors; Aged; Cells, Cultured; Female; Humans; Karyotyping; Lymphocytes; Middle Aged; Mi | 1989 |
Cis-platinum and mitomycin-C in treatment of recurrent, metastatic, or residual uterine cervical cancer post radiation.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cis | 1989 |
Concurrent radiation therapy, cis-platinum, and mitomycin C in patients with poor prognosis cancer of the cervix: a pilot study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modali | 1989 |
Treatment of recurrent cervical cancer with cis-platinum and mitomycin C: a phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Female; Humans; Middle A | 1989 |
Cytotoxicity mediated by tumor necrosis factor in variant subclones of the ME-180 cervical carcinoma line: modulation by specific inhibitors of DNA topoisomerase II.
Topics: Cell Communication; Cell Survival; DNA Topoisomerases, Type II; Drug Synergism; Etoposide; Female; K | 1989 |
Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, S | 1985 |
Mitomycin C in advanced cervical cancer.
Topics: Adenocarcinoma; Adult; Carcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Humans; M | 1987 |
Pharmacokinetics of mitomycin-C in plasma and tumor tissue of cervical cancer patients and in selected tissues of female rats.
Topics: Adenocarcinoma, Mucinous; Aged; Animals; Carcinoma, Squamous Cell; Female; Half-Life; Humans; Kineti | 1986 |
Clinical evidence of feasibility and efficacy of simultaneous irradiation and chemotherapy in advanced squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Brachytherapy; Carcinom | 1986 |
Spontaneous and MMC induced SCE in lymphocytes from patients with cervical cancer.
Topics: DNA Damage; Female; Humans; In Vitro Techniques; Lymphocytes; Mitomycin; Mitomycins; Neoplasm Stagin | 1986 |
[Sister chromatid exchange (SCE) in lymphocytes of patients with cancer of the cervix uteri].
Topics: Adult; Aged; Female; Humans; Leiomyoma; Lymphocytes; Middle Aged; Mitomycin; Mitomycins; Sister Chro | 1987 |
Mitomycin C induced chromosomal aberrations and sister chromatid exchanges (SCEs) in lymphocytes of patients with precancerous and cancerous lesions of the uterine cervix.
Topics: Chromosome Aberrations; Female; Humans; Lymphocytes; Mitomycin; Mitomycins; Precancerous Conditions; | 1987 |
[Side effects and anti-cancer effects following intraperitoneal (ip) administration of mitomycin C (MMC)].
Topics: Female; Humans; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneum; Ut | 1987 |
Concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after radical surgery.
Topics: Combined Modality Therapy; Female; Fluorouracil; Humans; Infusions, Intravenous; Mitomycin; Mitomyci | 1987 |
Preliminary results of concomitant radiotherapy and chemotherapy in advanced cervical carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Cesium Radi | 1987 |
[Isolation chemotherapy at the pelvic vascular bed in the management of advanced cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; | 1987 |
Synchronous 5-fluorouracil, mitomycin-C and radiation therapy in the treatment of locally advanced carcinoma of the cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; | 1988 |
Concomitant 5-fluorouracil, mitomycin-C, and radiotherapy for advanced gynecologic malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 1988 |
Chemotherapy for gynecologic malignancies at Siriraj Hospital, Bangkok.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamid | 1985 |
[A combination chemotherapy using mitomycin C, vincristine and cisplatin (MVP) for advanced cervical cancer].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Drug | 1985 |